Law FirmOpposition Filing Analysis

The comprehensive analysis of Brand Murray Fuller opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Brand Murray Fuller

Patent NumberTitleApplicantOpposition DateOpposition Company
Anticancer CompositionsARAGON PHARMACEUTICALSJul 9, 2025BRAND MURRAY FULLER
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSJul 9, 2025BRAND MURRAY FULLER
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEJun 18, 2025BRAND MURRAY FULLER
Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 AntagonistsNOVARTISMay 21, 2025BRAND MURRAY FULLER
Treatment Of Sepsis And Septic ShockCOMBIOXINMay 6, 2025BRAND MURRAY FULLER
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICSApr 24, 2025BRAND MURRAY FULLER
Manufacture Of DegarelixFERRINGApr 10, 2025ACCORD HEALTHCARE
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJan 24, 2025BRAND MURRAY FULLER
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025BRAND MURRAY FULLER
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionTHE MEDICINESJan 16, 2025INTAS PHARMACEUTICALS